Hormone replacement therapy for prevention - More evidence, more pessimism

被引:37
作者
Petitti, DB [1 ]
机构
[1] Kaiser Permanente So Calif, Res & Evaluat, Pasadena, CA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 01期
关键词
D O I
10.1001/jama.288.1.99
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:99 / 101
页数:3
相关论文
共 32 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]  
Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
[3]   Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries [J].
Angerer, P ;
Störk, S ;
Kothny, W ;
von Schacky, C .
MATURITAS, 2002, 41 (01) :51-60
[4]   Effect of oral postmenopausal hormone replacement on progression of atherosclerosis -: A randomized, controlled trial [J].
Angerer, P ;
Störk, S ;
Kothny, W ;
Schmitt, P ;
von Schacky, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) :262-268
[5]   Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial [J].
Black, DM ;
Thompson, DE ;
Bauer, DC ;
Ensrud, K ;
Musliner, T ;
Hochberg, MC ;
Nevitt, MC ;
Suryawanshi, S ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4118-4124
[6]   Hormone replacement therapy and reduced cognitive decline in older women - The Cache County Study [J].
Carlson, MC ;
Zandi, PP ;
Plassman, BL ;
Tschanz, JT ;
Welsh-Bohmer, KA ;
Steffens, DC ;
Bastian, LA ;
Mehta, KM ;
Breitner, JCS .
NEUROLOGY, 2001, 57 (12) :2210-2216
[7]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[8]   Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].
Ettinger, B ;
Black, DM ;
Mitlak, BH ;
Knickerbocker, RK ;
Nickelsen, T ;
Genant, HK ;
Christiansen, C ;
Delmas, PD ;
Zanchetta, JR ;
Stakkestad, J ;
Glüer, CC ;
Krueger, K ;
Cohen, FJ ;
Eckert, S ;
Ensrud, KE ;
Avioli, LV ;
Lips, P ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645
[9]   Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study [J].
Grady, D ;
Wenger, NK ;
Herrington, D ;
Khan, S ;
Furberg, C ;
Hunninghake, D ;
Vittinghoff, E ;
Hulley, S .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :689-+
[10]   Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].
Grady, D ;
Herrington, D ;
Bittner, V ;
Blumenthal, R ;
Davidson, M ;
Hlatky, M ;
Hsia, J ;
Hulley, S ;
Herd, A ;
Khan, S ;
Newby, LK ;
Waters, D ;
Vittinghoff, E ;
Wenger, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57